Xie Yonglin, general manager and co-ceo of Ping An Group, publicly responded that the original intention of Ping An's participation in the judicial reorganization of Founder Group was to create a unique and warm financial and insurance service for Ping An Group through the coordination of medical resources. The medical resources of Founder Group are very scarce in the market.

Founder Group, a Peking University International Hospital with China Ping An Health as its core advantage in the commercial field, Beida as a world-class pharmaceutical brand and medical sector, and the mission of "building a world-class hospital", is highly consistent with the strategic layout of China Ping An Medical and Health Ecosphere in terms of offline industry, research and application level of medical technology and large medical data accumulation.

The CBRC also pointed out that it is necessary to strengthen the sustainable management of equity investment, ensure the compliance of corporate governance procedures, maintain the independence and autonomy of decision-making, implement various risk control measures, ensure solvency and financial status, continue to comply with regulations to prevent market risks, operational risks, operational risks and reputation risks, and earnestly safeguard insurance funds and the legitimate rights and interests of parties.